These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
517 related items for PubMed ID: 30191987
1. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro. Liu Y, Ren CC, Yang L, Xu YM, Chen YN. J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987 [Abstract] [Full Text] [Related]
4. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention. Zheng N, Chen J, Li T, Liu W, Liu J, Chen H, Wang J, Jia L. Mol Carcinog; 2017 Aug; 56(8):1896-1908. PubMed ID: 28277622 [Abstract] [Full Text] [Related]
5. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer. Zheng N, Liu W, Chen J, Li B, Liu J, Wang J, Gao Y, Shao J, Jia L. Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564 [Abstract] [Full Text] [Related]
7. Pharmacological blockage of the CXCR4-CXCL12 axis in endometriosis leads to contrasting effects in proliferation, migration, and invasion. Ruiz A, Ruiz L, Colón-Caraballo M, Torres-Collazo BJ, Monteiro JB, Bayona M, Fazleabas AT, Flores I. Biol Reprod; 2018 Jan 01; 98(1):4-14. PubMed ID: 29161347 [Abstract] [Full Text] [Related]
8. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer. Zhu WB, Zhao ZF, Zhou X. J Cell Physiol; 2019 Jul 01; 234(7):11746-11759. PubMed ID: 30537000 [Abstract] [Full Text] [Related]
9. Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4. Ray P, Lewin SA, Mihalko LA, Schmidt BT, Luker KE, Luker GD. Neoplasia; 2011 Dec 01; 13(12):1152-61. PubMed ID: 22241961 [Abstract] [Full Text] [Related]
10. Role of CXCL12 in metastasis of human ovarian cancer. Jiang YP, Wu XH, Xing HY, DU XY. Chin Med J (Engl); 2007 Jul 20; 120(14):1251-5. PubMed ID: 17697577 [Abstract] [Full Text] [Related]
14. Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer. Mao TL, Fan KF, Liu CL. Gene Ther; 2017 Oct 20; 24(10):621-629. PubMed ID: 28753202 [Abstract] [Full Text] [Related]
15. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments. Liao YX, Fu ZZ, Zhou CH, Shan LC, Wang ZY, Yin F, Zheng LP, Hua YQ, Cai ZD. Oncol Rep; 2015 Jul 20; 34(1):33-42. PubMed ID: 25997540 [Abstract] [Full Text] [Related]
20. CXCL12-CXCR4 promotes proliferation and invasion of pancreatic cancer cells. Shen B, Zheng MQ, Lu JW, Jiang Q, Wang TH, Huang XE. Asian Pac J Cancer Prev; 2013 Aug 15; 14(9):5403-8. PubMed ID: 24175834 [Abstract] [Full Text] [Related] Page: [Next] [New Search]